Protein Assays Market 2027 Size, Share, Incredible Growth, Detailed Analysis and Business Prospects

Protein assays are gaining momentum in the healthcare sector for examining protein in sample concentrations. It plays a crucial role in life science researches which is anticipated to generate demand and investments over the next couple of years. The study offered by Market Research Future (MRFR) asserts that the global protein assays market is poised to register a double-digit CAGR of 10.8% through the forecast period 2017 to 2023.

The increasing demand for drug discovery and research is forecasted to expand the protein assays market in the years to come. Also, the growth of the biotechnology and pharmaceutical industries are likely to propel market proliferation during the projection period.

With the use of protein assays for early diagnosis of HIV and cancer have significantly reduced the mortality and morbidity of the disease. Protein assays are facile, cost-effective, and reproducible, which fuels its demand over the assessment period. Lowry, Bradford, UV spectroscopic, and BCA are some of the commonly used protein assays. The use of protein assays in drug discovery and development and disease diagnosis is encouraging the pharmaceutical and biotechnological sectors to invest in research and development activities. Such factors are estimated to propel the propel assays market growth throughout the estimated period.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5091 

Competitive Analysis:

The prominent players profiled for a detailed share analysis of the global protein assays market are GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Abcam plc (U.S.), Cell Signaling Technology Inc. (U.S.), Lucigen Corporation (U.S.), QIAGEN (Germany), PerkinElmer Inc. (U.S.), Lonza Group Ltd. (Switerzland), BioVision Inc. (U.S.), Bio-Techne (U.S.), Illumina Inc. (U.S.), Takara Bio Inc. (Japan), New England Biolabs (U.S.), Promega Corporation (U.S.), and F. Hoffmann-La Roche Ltd (Switerzland).

Market Segmentation:

The global protein assays market has been segmented on the basis of Type, Application, Product, Technology and End-users.

  • On the basis of Type, the global protein assays market has been segmented into test strip-based assays, copper-ion-based assays, dye-binding assays, and others.
  • On the basis of Application, the protein assays market has been segmented into drug discovery, protein purification, diagnosis, and others.
  • On the basis of Product, the global protein assays market has been segmented into instruments, reagents & kits, and others.
  • On the basis of Technology, the protein assays market has been segmented into fluorescence-based protein assays, colorimetric-based protein assays, and absorbance-based protein assays.
  • On the basis of End-user, the global protein assays market has been segmented into academic institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and others.

Regional Analysis:

By region, the global protein assays market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Americas is expected to hold a considerable share of the market and witness boom in the forthcoming years. The region is equipped with advanced technologies for supporting extensive research & development activities in the pharmaceutical and biotechnology industries. Increasing life science research projects for drug discovery and development in the region is likely to propel the expansion of the protein assays market over the next couple of years. In addition, the major players are based out of the region that holds significant positions in the market share analysis. The growth of these players is also anticipated to aid the growth of the market in the region.

Europe is prognosticated to contribute significantly to the development of the global market. The region is expected to observe high investments in the pharmaceutical and biotechnology industries in the forthcoming years. The favorable laws framed by the European Union for regulating healthcare sector is also poised to boost the expansion of the regional protein assays market over the next couple of years. In addition, the availability of funds by private and public organizations for research & development is anticipated to favor market expansion in the foreseeable future.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/protein-assays-market-5091 

Asia Pacific resonates promising opportunities for growth and is anticipated to benefit from the economic development in fast-developing nations such as China and India. China is investing in the development of the biotechnology industry. It is expected to catapult the protein assay market in the region on its trajectory of growth. The regional segment is also anticipated to observe increasing disposable income over the next few years. This, in turn, is expected to boost expenditure in the healthcare sector which is projected to favor market growth. Meanwhile, the Middle East & Africa is anticipated to demonstrate a moderate rise in the growth curve owing to developments in the healthcare sector of Middle Eastern regions.

Comments are closed